CJC-1295 without DAC and Ipamorelin are two synthetic peptides that each act on a specific receptor of the pituitary axis in research models. Within scientific research, they are studied together as a model pair for the interaction between two release pathways and as a reference standard in analytical work. This combination is offered as a 3 ml pre-filled injection pen containing 5 mg of each peptide, exclusively for laboratory and research purposes.<\/p>\n
The cartridge contains both peptides in a fixed 1:1 ratio, pre-combined in a single solution. CJC-1295 without DAC, also known in the literature as Mod GRF(1-29), is a modified fragment of 29 amino acids of the growth hormone-releasing hormone. Four amino acid substitutions at positions 2, 8, 15, and 27 make the chain more resistant to enzymatic degradation than the unmodified GRF(1-29); binding to the GHRH receptor is studied in research models.<\/p>\n
Ipamorelin is a selective pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2<\/sub> which acts on the growth hormone secretagogue receptor, also known as the ghrelin receptor. The two D-amino acids and the non-proteinogenic Aib at the start of the chain make the compound insensitive to the usual degradation pathways and provide a pronounced selectivity profile with respect to related secretagogues. Because both molecules act via a different receptor, pairing is considered in the literature as a classic model for studying the interplay between two signaling pathways.<\/p>\n In a laboratory context, this combination occurs in the following research areas, among others:<\/p>\n Cada uma destas aplica\u00e7\u00f5es envolve investiga\u00e7\u00e3o controlada em laborat\u00f3rio ou em modelos pr\u00e9-cl\u00ednicos.<\/p>\n This version belongs to the line of pre-filled injection pens: compounds contained in dissolved form in a sealed cartridge, so that a researcher does not need to go through their own dissolution step. The same combination is available elsewhere in the range as freeze-dried lyophilisate in a vial, and both peptides are also available separately. Other compounds within the pen line act on an entirely different biochemical system; the form indicates nothing about the substance class.<\/p>\n Both peptides are dissolved in a sealed 3 ml glass cartridge in a pen with a click mechanism. A separate dissolution step is not required with this version; the cartridge remains closed until a needle is inserted. The label includes a table showing the relationship between click settings and dispensed volume, allowing sample collections to be reproducibly recorded in a protocol.<\/p>\n Store the pen refrigerated between 2 and 8 \u00b0C, protected from light and in the original packaging. Handle the pen in a clean working environment, use a new sterile needle for each draw to prevent cross-contamination, and wear standard personal protective equipment. Keep the material out of reach of unauthorized persons.<\/p>\n Both raw materials have a controlled purity of \u2265 99% (HPLC). The pen contains the two peptides in a sterile aqueous base in a 1:1 ratio; the total amount per component is stated on the label.<\/p>\n\u00c1reas de investiga\u00e7\u00e3o<\/h2>\n
\n
CJC-1295 + Ipamorelin in our research assortment<\/h2>\n
Especifica\u00e7\u00f5es<\/h2>\n
\n\n
\n \nEspecifica\u00e7\u00e3o<\/th>\n Valor<\/th>\n<\/tr>\n<\/thead>\n \n Amostra<\/td>\n CJC-1295 without DAC (Mod GRF 1-29) + Ipamorelin<\/td>\n<\/tr>\n \n Sin\u00f4nimos<\/td>\n Modified GRF (1-29); tetra-substituted GRF(1-29) Ipamorelin: NNC 26-0161<\/td>\n<\/tr>\n \n Sequ\u00eancia<\/td>\n Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2<\/sub> \u00b7 CJC-1295: modified GRF fragment of 29 amino acids<\/td>\n<\/tr>\n \n N\u00famero CAS<\/td>\n 170851-70-4 (Ipamorelin)<\/td>\n<\/tr>\n \n F\u00f3rmula molecular \/ peso<\/td>\n C152<\/sub>H252<\/sub>N44<\/sub>O42<\/sub> \/ \u00b1 3367.9 Da \u00b7 C38<\/sub>H49<\/sub>N9<\/sub>O5<\/sub> \/ 711,9 Da<\/td>\n<\/tr>\n \n PubChem CID<\/td>\n 9831659 (Ipamorelin)<\/td>\n<\/tr>\n \n Aula<\/td>\n GHRH analog + selective pentapeptide, 1:1 combination<\/td>\n<\/tr>\n \n Forma<\/td>\n Pre-filled injection pen with sealed cartridge<\/td>\n<\/tr>\n \n Quantidade por unidade<\/td>\n 5 mg + 5 mg per 3 ml pen<\/td>\n<\/tr>\n \n Quantity per package<\/td>\n 1 pen, 10 pen needles and alcohol wipes<\/td>\n<\/tr>\n \n Armazenar<\/td>\n Refrigerated at 2\u20138 \u00b0C, store in a dark place.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Formato, manuseamento e armazenamento<\/h2>\n
Composi\u00e7\u00e3o e resultados laboratoriais<\/h2>\n